Does SIMVASTATIN Cause Hypercalcaemia? 42 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Hypercalcaemia have been filed in association with SIMVASTATIN (Simvastatin). This represents 0.2% of all adverse event reports for SIMVASTATIN.
42
Reports of Hypercalcaemia with SIMVASTATIN
0.2%
of all SIMVASTATIN reports
13
Deaths
39
Hospitalizations
How Dangerous Is Hypercalcaemia From SIMVASTATIN?
Of the 42 reports, 13 (31.0%) resulted in death, 39 (92.9%) required hospitalization, and 15 (35.7%) were considered life-threatening.
Is Hypercalcaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMVASTATIN. However, 42 reports have been filed with the FAERS database.
What Other Side Effects Does SIMVASTATIN Cause?
Myalgia (3,919)
Fatigue (2,066)
Arthralgia (1,775)
Drug interaction (1,744)
Nausea (1,676)
Rhabdomyolysis (1,616)
Dyspnoea (1,542)
Headache (1,470)
Drug hypersensitivity (1,433)
Muscular weakness (1,356)
What Other Drugs Cause Hypercalcaemia?
RITUXIMAB (857)
METHOTREXATE (803)
ADALIMUMAB (663)
TOCILIZUMAB (618)
ABATACEPT (612)
ETANERCEPT (602)
DENOSUMAB (599)
ALENDRONATE (594)
INFLIXIMAB (594)
LEFLUNOMIDE (585)
Which SIMVASTATIN Alternatives Have Lower Hypercalcaemia Risk?
SIMVASTATIN vs SINGULAIR
SIMVASTATIN vs SINTILIMAB
SIMVASTATIN vs SIPONIMOD
SIMVASTATIN vs SIPULEUCEL-T
SIMVASTATIN vs SIROLIMUS